Showing results (201-210 of 256) with videos related to
Sort By:
Pageof 26
Breast Cancer Research and Treatment|April 7, 2021
Multigene assessment of genetic risk for women for two or more breast cancersJeffrey N Weitzel, John Kidd, Ryan Bernhisel, et al.JCO Precision Oncology|July 29, 2021
Comprehensive Breast Cancer Risk Assessment for CHEK2 and ATM Pathogenic Variant Carriers Incorporating a Polygenic Risk Score and the Tyrer-Cuzick ModelShannon Gallagher, Elisha Hughes, Allison W Kurian, et al.Proteomics|June 3, 2010
Peptidomic profiling of human cerebrospinal fluid identifies YPRPIHPA as a novel substrate for prolylcarboxypeptidaseXuemei Zhao, Katie Southwick, Helene L Cardasis, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 25, 2019
Association between Clonal Hematopoiesis and Late Nonrelapse Mortality after Autologous Hematopoietic Cell TransplantationThomas P Slavin, Jennifer Berano Teh, Jeffrey N Weitzel, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 2, 2022
Clonal Hematopoiesis and Mosaicism Revealed by a Multi-Tissue Analysis of Constitutional TP53 StatusDanielle Castillo, Tze-An Yuan, Bita Nehoray, et al.Proceedings of the National Academy of Sciences of the United States of America|March 25, 2018
Rlip depletion prevents spontaneous neoplasia in TP53 null miceSanjay Awasthi, Joshua Tompkins, Jyotsana Singhal, et al.Prostate Cancer and Prostatic Diseases|September 5, 2024
Active surveillance selection and 3-year durability in intermediate-risk prostate cancer following genomic testingLauren Lenz, Wyatt Clegg, Diana Iliev, et al.Journal of the American Geriatrics Society|April 24, 2019
The Burden of Breast Cancer Predisposition Variants Across The Age Spectrum Among 10 000 PatientsYanin Chavarri-Guerra, Carolyn B Hendricks, Sandra Brown, et al.Endocrinology, Diabetes & Metabolism|March 1, 2019
A comparative study of the binding properties, dipeptidyl peptidase-4 (DPP-4) inhibitory activity and glucose-lowering efficacy of the DPP-4 inhibitors alogliptin, linagliptin, saxagliptin, sitagliptin and vildagliptin in miceJoel P Berger, Ranabir SinhaRoy, Alessandro Pocai, et al.Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|June 3, 2010
Expression, purification and crystallization of human prolylcarboxypeptidasePravien D Abeywickrema, Sangita B Patel, Noel J Byrne, et al.Pageof 26